08 May 2023
ASTHMA AUSTRALIA’S 2023 TASMANIAN ASTHMA DISCOVERY SURVEY – TELL US YOUR STORY!
Asthma Australia wants to know more about what life is like for Tasmanians experiencing breathing problems and asthma.
08 May 2023
Publication of Notification Form for likely or actual breach of minimum stockholding requirements
Publication of Notification Form for likely or actual breach of minimum stockholding requirements
08 May 2023
Hydrocortisone shortage
The Therapeutic Goods Administration is aware of a shortage of all hydrocortisone tablet strengths due to manufacturing issues. We are working with the supplier Alphapharm Pty Ltd to manage the impact.
08 May 2023
Hydrocortisone tablet shortage has resolved
Alphapharm, the sponsor of Hysone and Hydrocortisone Viatris brands of hydrocortisone tablets, has advised that all strengths are available again. The 4mg and 20mg strengths had been unavailable since 27 March 2023.
05 May 2023
COVID-19 update 5 May 2023
COVID Cases in SA There have been 2,363 new cases of COVID-19 reported in South Australia in the past week.
05 May 2023
Public Drug Warning: Potent opioid (isotonitazene) found in drugs in yellow powder form
NSW Health is warning of the potential dangers from a potent opioid (isotonitazene) detected in drugs in a yellow powder form on the NSW Central Coast. The powder may be related to recent deaths which are under investigation.
05 May 2023
Updated Agenda for the July 2023 PBAC meeting
Updated Agenda for the July 2023 PBAC meeting
05 May 2023
EU MDR transition extension
The TGA recently implemented an EU MDR transition strategy for Australian medical device sponsors and stakeholders.
05 May 2023
We want you to help us plan the 2024 national conference
Expressions of interest are sought for members to plan the 2024 AMA National Conference.